Omnicin has developed an ‘antibiotic booster’
The Groningen-based company Omnicin has developed a method for using existing antibiotics successfully in the fight against resistant bacterial infections, says Northern Knowledge. The company intends to produce a ‘booster’ for existing antibiotics that can also treat resistant bacterial infections.
Bacterial resistance to known antibiotics is an increasingly important global issue, with significant research oriented towards the problem. One of the researchers at the University of Groningen, Professor Dr. Oscar Kuipers, found that gram-negative bacteria’s ‘extra layer’ (that blocks antibiotics from entering the bacteria) could be broken down using a ‘booster’, reports the GIC. This means that existing antibiotics can still be used.
The company Omnicin will further this work, having patented the technique and obtained a license for its development. Prof. Dr. Kuipers is Omnicin’s Scientific Adviser.